ArticleHeliyon2023
Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model.
Cécile Hérate et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ArticleHeliyon2023
Cécile Hérate et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.